New Revenue and Customer Service Channels for Diagnostics Laboratories
Expand Offerings to Healthcare Customers through new Last Mile TeleDiagnostics Options
Increasingly Competitive Environment for Diagnostics: Who Will Win the Race?
COVID massively increased the number of diagnostics laboratories from high complexity to CLIA-waived organizations in the United States. Internationally, similar occurrences changed the competitive landscape.
New diagnostics upstarts now continue to challenge larger, institutional labs, through aggressive–and often technologically driven–competitors backed by renewed enthusiasm for a wide array of diagnostics advancements.
Our platform supports this movement toward at-home and remote “TeleDiagnostics” with a full service solution enabling:
At-home self-collection
At-home blood draws
In-field testing and corporate wellness events
Direct-to-consumer and corporate Ecommerce enablement
Automatic shipping and exception handling
Build vs. License: What Approach is Right to Enable New Revenue Channels?
Until our platform arrived on the scene, labs have had to decide one of three paths:
Mash up a collection of manual processes;
Architect and build our own technology and grow slowly over time; or
License a platform that might limit their pace of growth.
Our Platform eliminates the need to build and maintain in-house technology while providing the broadest set of configurable capabilities to support a number of new revenue channels diagnostics laboratories might otherwise not pursue:
Expanded services for healthcare clients (medical groups, hospitals, group homes, etc.)
Direct-to-consumer Ecommerce for remote diagnostics
Employer wellness services for in-person and remote testing events
Medical device remote setup and usage quality assurance
Medicine compliance services
Increasingly Competitive Environment for Diagnostics: Who Will Win the Race?
COVID massively increased the number of diagnostics laboratories from high complexity to CLIA-waived organizations in the United States. Internationally, similar occurrences changed the competitive landscape. New diagnostics upstarts now continue to challenge larger, institutional labs, through aggressive–and often technologically driven–competitors backed by renewed enthusiasm for a wide array of diagnostics advancements. While, in the United States and globally, there are leading diagnostics organizations, never has it been more possible for smaller organizations to provide advanced, technologically driven services, to level the playing field.
Our platform supports this movement toward at-home and remote “TeleDiagnostics” with a full service solution enabling:
At-home self-collection
At-home blood draws
In-field testing and corporate wellness events
Direct-to-consumer and corporate Ecommerce enablement
Automatic shipping and exception handling
Build vs. License: What Approach is Right to Enable New Revenue Channels?
Until our platform arrived on the scene, labs have had to decide one of three paths:
Mash up a collection of manual processes
Architect and build our own technology and grow slowly over time or
License a platform that might limit their pace of growth.
Our platform eliminates the need to build and maintain in-house technology while providing the
broadest set of configurable capabilities to support a number of new revenue channels diagnostics laboratories might otherwise not pursue: